Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$475K Buy
13,445
+3,324
+33% +$135K 0.01% 969
2025
Q4
$416K Sell
10,121
-2,016
-17% -$87.7K 0.01% 1016
2025
Q3
$573K Buy
12,137
+4,729
+64% +$245K 0.01% 864
2025
Q2
$387K Buy
7,408
+900
+14% +$49.4K 0.01% 1036
2025
Q1
$394K Sell
6,508
-158
-2% -$10.2K 0.01% 954
2024
Q4
$461K Sell
6,666
-492
-7% -$34.3K 0.01% 947
2024
Q3
$490K Buy
7,158
+1,209
+20% +$85.3K 0.01% 916
2024
Q2
$399K Buy
+5,949
New +$434K 0.01% 930

Other funds holding CNMD

Choreo LLC's CNMD Position: Q1 2026 in Review

Choreo LLC increased its CONMED (CNMD) stake by 33% in Q1 2026, buying an estimated $135K and bringing the position to 13,445 shares worth $475K. The position accounts for 0.01% of the portfolio, ranked #969.

Choreo LLC first reported a position in CNMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $573K in Q3 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Choreo LLC held 13,445 shares of CONMED worth $475K as of Q1 2026.
  • Choreo LLC bought 3,324 CONMED shares in Q1 2026, an estimated $135K.
  • CONMED made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #969 holding.
  • Choreo LLC first reported a position in CONMED in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's CONMED position peaked at $573K in Q3 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.